News
Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and ...
A long list of Lynda Hollander's paternal relatives had heart disease, and several had undergone major surgeries. So when she ...
A new research paper featured on the cover of Volume 17, Issue 7 of Aging (Aging-US) was published on July 25, 2025, titled ...
Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and aging are locked in a vicious circle: ...
A new study led by researchers at the Ineos Oxford Institute for antimicrobial research (IOI) has found that antimicrobial ...
Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires ...
In a study published in Advanced Materials on July 22, a team led by Dr. ZHONG Chao and Dr. AN Bolin from the Shenzhen ...
Research shows dietary copper intake boosts cognitive function in older adults, particularly those with a stroke history, ...
A little-known federal agency that sends more than $12 billion annually to support community health centers, addiction ...
New radioimmunotherapy approach eliminates cancer stem cells in preclinical models of ovarian cancer
A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ...
The rise of vaping in youth correlates with increased smoking risk, undermining public health efforts. Study calls for ...
A two-drug combination for treating advanced kidney cancer had sustained and durable clinical benefit in more than five years of follow-up, according to a study published Aug. 1 in Nature Medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results